International scientists say deuterium research could reshape medicine
The conference highlighted research suggesting that deuterium levels may influence key biological processes
The conference highlighted research suggesting that deuterium levels may influence key biological processes
Libre Duo devices become the first glucose-ketone monitors approved for diabetes care, offering real-time alerts for diabetic ketoacidosis risk
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
Clears major obesity endpoints at 80 weeks
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
Eris Lifesciences posts sharp profit surge in FY26 driven by strong diabetes portfolio growth
All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
Subscribe To Our Newsletter & Stay Updated